NEW YORK (GenomeWeb) – The Mayo Clinic Center for Individualized Medicine and Whole Biome announced on Tuesday a collaboration to develop microbiome-targeted diagnostics.

The initial focus will be on women's health, and in particular preterm labor, the most common cause of infant death and a leading cause of long-term disability in children, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.